| Climate Changes for Medical Devices The U.S. health-care overhaul could help hospitals cut costs for high-priced medical devices, heightening a long-term threat for manufacturers already facing pressure on product prices. online.wsj.com |
Keryx Biopharm: Real Moves Yet to Materialize VFC submits: Keryx Biopharmaceuticals (KERX) announced on Wednesday that the FDA has granted Orphan Drug status for perifosine in the treatment of neuroblastoma, a cancer of the nervous system mostly affecting children. There are currently no FDA approved therapies for this condition, according to publicly available information.Positive Phase I data for perifosine in the treatment of this indication was presented at this year's ASCO conference. Complete Story » seekingalpha.com |
Ironwood Pharmaceuticals Announces Second Quarter 2010 Investor Update Call (Business Wire) CAMBRIDGE, Mass.----Ironwood Pharmaceuticals, Inc. today announced it will issue its second quarter 2010 investor update after the U.S. financial markets close on Thursday, August 5, 2010. us.rd.yahoo.com |
NeoStem Buys Cell Therapy Service Company ChinaBio Today submits: NeoStem (NBS) has signed a definitive agreement to acquire Progenitor Cell Therapy, LLC, a US cell therapy service company. NeoStem said the transaction will be immediately accretive to earnings. NeoStem did not address the question of whether it would offer Progenitor's services in China.Progenitor provides its clients with a variety of services, including contract manufacturing, product and process development, consulting, GTP services and national distribution. It played an instrumental role in manufacturing Provenge, Dendreon’s (NYSE: DNDN) autologous cellular immunotherapy, for its clinical trials. The company’s operations are in New Jersey and California. Complete Story » seekingalpha.com |
Tylenol 8-Hour Caplets Recalled on Musty Odor A Johnson & Johnson unit said it is recalling more than 100,000 bottles of Tylenol 8-Hour caplets after a small number of complaints about a musty or moldy odor. online.wsj.com |